Track TetraLogic Pharmaceuticals's current cash ($5.9M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
TetraLogic Pharmaceuticals (TLOG) currently reports a current cash of $5.9M as of September 2016. That compares with $16M in the prior-year period — down 63.0% year over year. Use the charts on this page to explore TetraLogic Pharmaceuticals's current cash history and peer comparisons.
TetraLogic Pharmaceuticals's current cash decreased from $16M to $5.9M — a 63.0% year-over-year decrease (period ending September 2016). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
TetraLogic Pharmaceuticals reported $5.9M in current cash as of September 2016. That compares with $16M in the prior-year period — down 63.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current cash of $5.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for TetraLogic Pharmaceuticals, and consider following TLOG for alerts when major investors trade the stock.
TetraLogic Pharmaceuticals is classified in the Healthcare sector. On current cash, it currently shows $5.9M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TLOG with unrelated industries.